Drug Shortage Report for METHYLENE BLUE INJECTION USP
Report ID | 44896 |
Drug Identification Number | 02431548 |
Brand name | METHYLENE BLUE INJECTION |
Common or Proper name | Methylene Blue Injection |
Company Name | HIKMA CANADA LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | METHYLENE BLUE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5 ML |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-03-31 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2018-04-04 |
Company comments | Long term backorder; global API shortage |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-04-04 | French | Compare |
v5 | 2018-04-04 | English | Compare |
v4 | 2018-04-04 | English | Compare |
v3 | 2018-04-04 | French | Compare |
v2 | 2018-04-04 | English | Compare |
v1 | 2018-04-04 | English | Compare |
Showing 1 to 6 of 6